Gadoxetic Acid
drugOn this page
Also known as Acide gadoxetiqueAcido gadoxeticoGadoxetate
Summary
Gadoxetic Acid (CHEMBL2221312) is an approved small molecule (ATC V08CA10).
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Small molecule
- ATC class: V08CA10
- Clinical trials: 2
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2221312 |
| Name | Gadoxetic Acid |
| Type | Small molecule |
| Max phase | 4 |
| ATC | V08CA10 |
Also known as: Acide gadoxetique, Acido gadoxetico, Gadoxetate, Gadoxetic acid, GADOXETIC ACID
Parent form; salt/anhydrous children: CHEMBL2103740
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indications (0 at ChEMBL trial phase 4).
Clinical trials
Total trials: 2.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE4 | 1 |
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01575574 | PHASE4 | COMPLETED | Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis |
| NCT02395991 | Not specified | COMPLETED | Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.